03.05.24 |
Novo Nordisk Buy |
Deutsche Bank AG |
|
03.05.24 |
A.P. Moeller - Maersk A-S Neutral |
Goldman Sachs Group Inc. |
|
03.05.24 |
Novo Nordisk Overweight |
JP Morgan Chase & Co. |
|
02.05.24 |
Novo Nordisk Overweight |
Barclays Capital |
|
02.05.24 |
A.P. Moeller - Maersk A-S Neutral |
Goldman Sachs Group Inc. |
|
02.05.24 |
Novo Nordisk Neutral |
UBS AG |
|
02.05.24 |
A.P. Moeller - Maersk A-S Buy |
UBS AG |
|
02.05.24 |
A.P. Moeller - Maersk A-S Underperform |
Bernstein Research |
|
02.05.24 |
Novo Nordisk Overweight |
JP Morgan Chase & Co. |
|
02.05.24 |
Novo Nordisk Underperform |
Jefferies & Company Inc. |
|
03.04.24 |
A.P. Moeller - Maersk A-S Buy |
UBS AG |
|
15.12.23 |
A.P. Moeller - Maersk A-S Overweight |
JP Morgan Chase & Co. |
|
13.12.23 |
A.P. Moeller - Maersk A-S Overweight |
JP Morgan Chase & Co. |
|
08.11.23 |
A.P. Moeller - Maersk A-S Overweight |
JP Morgan Chase & Co. |
|
03.11.23 |
A.P. Moeller - Maersk A-S Buy |
UBS AG |
|
03.11.23 |
A.P. Moeller - Maersk A-S Sell |
Goldman Sachs Group Inc. |
|
03.11.23 |
A.P. Moeller - Maersk A-S Neutral |
JP Morgan Chase & Co. |
|
11.10.23 |
A.P. Moeller - Maersk A-S Sell |
Deutsche Bank AG |
|
13.09.23 |
Novo Nordisk Buy |
Deutsche Bank AG |
|